marijuana stocks

Insys Therapeutics tops 4Q revenue forecasts

Insys Therapeutics posts 4Q revenue of $66.5 million, result beats expectations

CHANDLER, Ariz. (AP) — Insys Therapeutics Inc. (INSY) on Tuesday reported fourth-quarter net income of $9.3 million.

On a per-share basis, the Chandler, Arizona-based company said it had net income of 25 cents. Earnings, adjusted for stock option expense, were 53 cents per share.

The specialty pharmaceutical company posted revenue of $66.5 million in the period, surpassing Street forecasts. Analysts expected $64.6 million, according to Zacks.

For the year, the company reported profit of $38 million, or $1.04 per share. Revenue was reported as $222.1 million.

Insys Therapeutics shares have risen 33 percent since the beginning of the year. The stock has increased 25 percent in the last 12 months.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSY at https://www.zacks.com/ap/INSY

_____

Keywords: Insys Therapeutics, Earnings Report


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$MJNA Continues National Expansion

Photo Release — Medical Marijuana, Inc.’s Kannaway Continues National Expansion Kannaway Brings…

$FITX Income Statement

Creative Edge Nutrition, Inc. (FITX) Income Statement Get Income Statement for: View:…

22nd Century Group, Inc. (XXII) Announces 1-for-15 Reverse Stock Split

22nd Century Announces 1-for-15 Reverse Stock Split 22nd Century Group, Inc. (Nasdaq:…

Canopy Growth Corporation (CGC) and Acreage Implement Amended Arrangement

Canopy Growth and Acreage Implement Amended Arrangement Canopy Growth Corporation (“Canopy Growth”)…